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ABSTRACT. Systemic lupus erythematosus (SLE) is a complex 
autoimmune disorder presenting heterogeneous clinical manifestations. 
A number of genes involved in SLE susceptibility are related to the type 
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I interferon (IFN) pathway. IFN mediates innate immune responses and 
its increased levels contribute to the breakdown of peripheral tolerance. 
Interferon-induced helicase C domain 1 (IFIH1) activates and modulates 
IFN responses through its caspase recruitment domain. In this study, 
we analyzed four IFIH1 single nucleotide polymorphisms (SNPs): 
rs6432714, rs10930046, rs1990760, and rs3747517, in 337 patients 
with SLE and 373 healthy individuals from southeast and northeast 
Brazil. Our results did not find an association between IFIH1 SNPs and 
SLE (P value >0.025 after Bonferroni’s adjustment). However, meta-
analysis of peer-reviewed articles from 2008 to 2015 and data from this 
study indicated an association between rs1990760 and SLE onset (P < 
0.05). This is the first association analysis on IFIH1 polymorphisms 
and SLE susceptibility in Brazilian populations.
Key words: IFIH1; SLE; SNPs; SLE clinical manifestations; 
Meta-analysis
INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder 
characterized by the formation of pathogenic autoantibodies against nuclear antigens 
and breakdown of self-tolerance. SLE etiology is not completely known, and genetic 
predisposition and environmental factors play a key role in its pathogenesis. Additionally, 
SLE presents extensive and heterogeneous clinical manifestations varying according 
to ancestry, geography, and particularly gender (Tsokos, 2011). Several of the genes 
associated with SLE seem related to the type I interferon (IFN) pathway, and lead to 
increased serum levels of IFN-inducible genes, known as “IFN-signature” (Tsokos, 2011; 
Choubey, 2012).
Interferon-induced helicase C domain 1 (IFIH1) gene, located at chromosome 2 
(2q24), encodes the homonymous protein, which recognizes viral dsRNA in the cytoplasm of 
infected cells and modulates IFN responses, such as production of pro-inflammatory cytokines 
and apoptotic processes (Chistiakov, 2010). Genetic association studies have confirmed that 
IFIH1 is involved in autoimmune disorders, such as type 1 diabetes and Graves’ disease; 
recently a link to SLE has been investigated (Smyth et al., 2006; Sutherland et al., 2007; 
Gateva et al., 2009). These studies have revealed that high levels of IFIH1 in lupus-prone mice 
could accelerate autoimmune processes and exacerbate the disease by increasing the levels 
of antinuclear autoantibodies (Crampton et al., 2012). Moreover, increased levels of IFIH1 
in tissue-specific regions of chronic discoid lupus erythematosus patients (Zahn et al., 2011) 
indicate a key role in predisposition to SLE.
The association between IFIH1 polymorphisms and SLE has been investigated in 
different populations, but not in the Brazilian one. In this study, we assessed the association 
between four IFIH1 polymorphisms (rs6432714, rs10930046, rs1990760, and rs3747517) 
and SLE pathogenesis, as well as its clinical manifestations in Brazilian patients from two 
different cohorts. In addition, we conducted a meta-analysis of recent literature involving 
IFIH1 rs1990760 and SLE susceptibility.
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MATERIAL AND METHODS
Subjects
We evaluated 337 SLE patients and 373 healthy controls from two Brazilian cohorts 
identified as Southeast - Division of Clinical Immunology, University Hospital of the School of 
Medicine of Ribeirão Preto, University of São Paulo; and Northeast - Division of Rheumatology 
of Hospital das Clínicas, Federal University of Pernambuco. All clinical features of the cohorts 
are reported in Table 1. The present study was approved by the local Ethics Committees: 
Southeast CEP/HCRP/FMRP #2234/2007 and Northeast CAAE 03065312.3.0000.5208. SLE 
diagnosis was performed according to the criteria of the American College of Rheumatology.
NA, not available.
Table 1. Demographic and clinical features from the two Brazilian cohorts.
Healthy controls Southeast (N = 186) Northeast (N = 187) 
Gender   
Male 49% 25% 
Female 51% 75% 
Mean age (± SD) 37 (11) 31 (13) 
Systemic lupus erythematosus (SLE) patients (N = 153) (N = 184) 
Gender   
Male 7% 1% 
Female 93% 99% 
Mean age (± SD) 37.8 (12) 32 (7) 
Mean age at diagnosis (± SD) NA 31 (8) 
Ethnic group   
European derived 76% 11% 
African derived 24% 89% 
Clinical/laboratorial characteristics   
Malar rash 56% 58.9% 
Discoid rash 16% 17.8% 
Photosensitivity 28.5% 67.3% 
Ulcers NA 19.6% 
Arthritis 43% 72% 
Serositis 25% 22.4% 
Nephritic disorder 55% 50.5% 
Neuropsychiatric disorder 19% 7.5% 
Hematological alterations 53% 68.2% 
Antinuclear antibody 82% 93.5% 
Anti-DNA antibody (anti-dsDNA) 21.5% 24.4% 
Anti-Sm antibody NA 8.42% 
Antiphospholipid syndrome 21% 5.6% 
 
SNP selection and IFIH1 genotyping
Genomic DNA was extracted from peripheral whole blood using a salting out 
procedure as described by Sambrook et al. (1989). We selected four single nucleotide 
polymorphisms (SNPs) within IFIH1: rs6432714 (A > T), rs10930046 (T > C), rs1990760 (C 
> T), and rs3747517 (A > G).
All SNPs presented a minor allele frequency of at least 10%. They were selected using 
the SNPbrowser software 4.0 (Applied Biosystems, Foster City, CA, USA) and the HapMap 
database (http://hapmap.ncbi.nlm.nih.gov/). The tag SNP rs6432714 was located at intron 7, 
covering the region from intron 6 to intron 7 by linkage disequilibrium. The non-synonymous 
4J. De Azevedo Silva et al.
Genetics and Molecular Research 15 (4): gmr15048008
SNP rs10930046 was located at exon 7. SNP rs1990760 was located within exon 15 encoding 
an alanine to threonine amino acid change at codon 946 (Ala946Thr) (Zhao et al., 2007). SNP 
rs3747517 was located at exon 13, encoding a missense mutation (Wang et al., 2013).
Genotyping was performed with commercially available fluorogenic allele-specific 
probes (TaqMan Probes; Applied Biosystems) using the ABI 7500 real-time PCR platform 
(Applied Biosystems). Allelic discrimination followed manufacturer protocols. Data were 
analyzed using the SDS software 2.3 (Applied Biosystems).
Statistical and meta-analysis
Hardy-Weinberg equilibrium (HWE) and SNP association tests between genotypes 
were performed using the exact test and the likelihood ratio test, respectively. Association 
tests between alleles were performed applying the chi-square test with Yate’s correction for 
continuity. Estimate of the best genetic model was made by Akaike’s information criterion. All 
analyses were performed using SNPassoc package for R v.3.0.2 (González et al., 2007). Linkage 
disequilibrium was calculated using the Haploview software v. 4.2 (Barrett et al., 2005). Post hoc 
statistical power tests were performed using the G*Power software v.3.1.3 (Faul et al., 2009). P 
values <0.025 were considered statistically significant after Bonferroni’s correction.
Meta-analysis searches were performed by two researchers, who separately entered 
the key words “IFIH1 and SLE” in the PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) 
and Periodicals CAPES (http://www.periodicos.capes.gov.br/) databases. Eleven and 109 
articles were retrieved, respectively. Finally, IFIH1 rs1990760 was assessed in nine different 
association studies from six peer-reviewed articles, including a genome-wide association 
study (GWAS) (SLEGEN et al., 2008; Gateva et al., 2009; Gono et al., 2010; Cunninghame 
Graham et al., 2011; Cen et al., 2013a; Enevold et al., 2014). All articles ranged from 2008 
to 2015 (Figure 1). Meta-analysis also included our data on rs1990760 from Northeast and 
Southeast Brazilian cohorts; workflow is shown in Figure 1. HWE was performed by applying 
the chi-square test. Allele and genotype frequencies, as well as sample size of SLE and control 
groups for each selected paper were analyzed. When the Q test for heterogeneity gave P values 
<0.10, the DerSimonian-Laird random-effects model was applied using the metafor package 
for R (Viechtbauer, 2010). Publication bias in meta-analyses was assessed for asymmetry 
using a funnel plot graph (Figure 2).
Figure 1. Schematic workflow indicating the criteria for meta-analysis.
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RESULTS
We genotyped 337 SLE patients, 153 from Southeast (93% females, 7% males) and 
184 from Northeast (99% females, 1% male) cohorts; and 373 healthy controls, 186 from 
Southeast (51% females, 49% males) and 187 from Northeast (75% females, 25% males) 
cohorts. The allele and genotype distributions from all tested SNPs within the IFIH1 gene 
were in HWE, except for rs10930046 in patients from the Southeast cohort (P = 0.045). No 
associations were found in any population between the polymorphisms and SLE susceptibility 
or its clinical manifestations after Bonferroni’s adjustment (Table 2). Power analysis indicated 
a variation 0.09-0.91. We considered an a error probability of 0.05 in the calculations.
Haplotype analysis indicated strong linkage disequilibrium between rs6432714 
and rs10930046 (D’ = 0.96) in the Southeast cohort, as well as among all studied 
polymorphisms in the Northeast cohort [D’ = 0.99 (rs6432714 and rs10930046) and D’ = 
0.91 (rs1990769 and rs3747517), respectively]. However, no association was found with 
SLE in any of the studied populations.
Figure 2. Asymmetry test funnel plot graph for meta-analysis.
N = number of individuals; OR = odds ratio; CI = confidence interval. Binary logistic regression adjusted by gender 
and origin of sample is also shown.
Table 2. IFIH1 SNP genotype frequencies in systemic lupus erythematosus patients (SLE) and healthy 
controls (HC) from two Brazilian cohorts. 
SNP Genotypes SLE HC OR CI(95%)  P 
N % N % 
rs6432714 AA 209 62 247 68.6 1 - - 
AT 114 33.8 99 27.5 0.72 0.5-1.03 0.07 
TT 14 4.2 14 3.9 0.94 0.42-2.12 0.88 
rs10930046 TT 176 63.5 259 69.4 1 - - 
TC 93 33.6 101 27.1 0.7 0.48-1.01 0.06 
CC 8 2.9 13 3.5 1.1 0.41-2.76 0.9 
rs1990760 CC 97 30.3 93 30.3 1 - - 
CT 163 50.9 151 49.2 0.93 0.65-1.35 0.71 
TT 60 18.8 63 20.5 1.13 0.71-1.79 0.61 
rs3747517 CC 171 51.7 158 50.6 1 - - 
CT 135 40.8 132 42.3 1.07 0.77-1.48 0.69 
TT 25 7.6 22 7.1 0.95 0.51-1.77 0.88 
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In the meta-analysis study, we considered rs1990760 frequencies in 6613 patients with 
SLE worldwide and in 22,818 healthy controls. According to the allele model, we observed a sta-
tistically significant (P < 0.05) overall association with SLE protection (OR = 0.93, 95%CI = 0.85-
0.99, P = 0.0266) when comparing C versus T alleles (Figure 3). The analysis also indicated het-
erogeneity (t2) of 0.01. Genotype distributions from all studies included in the meta-analysis were 
in HWE. In addition, sensitivity analysis was applied to estimate the influence of a specific study 
on meta-analysis. The results of removing each study, one by one, from the analysis are shown in 
Table 3. The asymmetry test did not identify a publication bias (P = 0.4462), as reported in Figure 2.
Table 3. Sensitivity analysis using IFIH1 rs1990760 for meta-analysis.
OR 95%CI.lb 95%CI.ub P|z| I^2 P|Q| 
0.9259 0.8492 1.0095 0.0808 64.7178 0.0025 
0.9290 0.8508 1.0143 0.1005 62.1441 0.0047 
0.9272 0.8490 1.0126 0.0929 63.9792 0.0030 
0.9265 0.8504 1.0095 0.0810 64.4872 0.0026 
0.9128 0.8425 0.9891 0.0258 64.9680 0.0023 
0.9050 0.8339 0.9822 0.0169 59.0967 0.0089 
0.8864 0.8362 0.9396 0.0001 31.5964 0.1556 
0.9200 0.8481 0.9979 0.0445 65.5846 0.0019 
0.9307 0.8619 1.0050 0.0670 60.7962 0.0063 
0.9166 0.8456 0.9937 0.0345 65.6024 0.0019 
0.9066 0.8400 0.9786 0.0119 61.7967 0.0051 
 OR = odds ratio; CI = confidence interval; lb = lower confidence interval bound; ub = upper interval bound; I^2 = 
measures the meta-analysis inconsistency.
Figure 3. Allele model depicting all studies included in meta-analysis of SNP rs1990760.
DISCUSSION
IFN plays an important role in SLE pathogenesis by enhancing autoimmune processes 
and disease complications (Lenert, 2010). Studies on IFN-induced genes improve our 
understanding of the regulatory mechanisms involved in activity and development of SLE. IFIH1 
acts as a cytoplasmic sensor for dsRNA, causing activation of NF-kB, IFN-regulatory factors 3 
and 7, and increased IFN production (Enevold et al., 2014). Additionally, IFIH1 is expressed in 
different cells of the immune system, playing a significant role in autoimmune diseases (Cen et 
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al., 2013b). Herein, we performed a genetic association study between IFIH1 polymorphisms 
and SLE predisposition, as well as its clinical manifestations, in two different Brazilian cohorts: 
Southeast and Northeast. We also carried out meta-analysis between IFIH1 rs1990760 and SLE 
susceptibility, as this particular polymorphism is the focus of most attention worldwide.
In this study, we identified negative associations in both cohorts. The tested SNPs 
were located throughout IFIH1, mainly from intron 7 (rs6432714) to exon 15 (rs3747517). 
rs6432714 has never been investigated in patients with SLE; however, it has been associated 
with type 1 diabetes, an autoimmune disease, in the population of northeast Brazil (Moura et 
al., 2013). Recently, a whole-genome admixture mapping study identified IFIH1 rs10930046 
to be related to apoptosis, inflammation, and autoantibody production in patients with SLE 
(Molineros et al., 2013). In this study, we did not find any association between rs10930046 
and SLE or its clinical features, confirming an earlier finding by Wang et al. (2013). However, 
the same study identified a protective effect against SLE development when performing a 
combined analysis with IFIH1 rs78456138 and rs3747517.
IFIH1, which recognizes dsRNA viruses, has been proposed as a potential SLE activator. 
It has been implicated in the production of autoantigens, such as the RNA binding Ro60 KD 
antigen, and molecular mimicry (James et al., 1997; McClain et al., 2005; Stathopoulou et al., 
2005). Viral infections may increase the level of lupus autoantigens by promoting cellular injury 
and apoptosis (Lenert, 2010). The first confirmed association involving IFIH1 SNPs and SLE 
was made by Gateva et al. (2009), who identified the altered risk of SLE derived from the A946T 
polymorphism (rs1990760) in populations from Sweden and the USA. Later, these results were 
replicated by Cunninghame Graham et al. (2011), confirming that risk allele A or protective 
allele G were associated to SLE onset. Our results reinforced a previous GWAS, which reported 
a trend for association between rs1990760 and SLE susceptibility (SLEGEN et al., 2008).
rs1990760 is located within the RIG-1 regulatory domain encoded by exons 14-
16 and was linked to increased IFN-a levels in patients with SLE positive for anti-dsDNA 
autoantibodies (Robinson et al., 2011; Molineros et al. 2013). rs1990760 is also the most 
studied IFIH1 SNP associated with SLE, and has been demonstrated to increase IFIH1 
expression. This may lead to an IFN cascade initiated by nucleic acids (Guerra et al., 2012), 
and characteristic of SLE pathogenesis (Cen et al., 2013b).
The updated meta-analysis in our study showed association between rs1990760 and 
SLE, pointing towards a protective role for the C allele, thus reinforcing previous results by 
Gateva et al. (2009) and Enevold et al. (2014). Despite the overall divergent results obtained 
with rs1990760 in SLE (Figure 2), our meta-analysis indicates either a protective association 
for the C allele or no association at all. These differences might be explained by taking into 
account the heterogeneous genetic background of the populations included in this and other 
studies, as also proposed by Enevold et al. (2014). Sensitivity analysis estimates indicate that 
a large number of studies are required to produce more robust meta-analysis results.
In conclusion, our genetic association study on two different Brazilian cohorts, did not 
detect any association between the tested SNPs and SLE susceptibility or its clinical features. 
However, meta-analysis showed association between IFIH1 rs1990760 and SLE, indicating 
that the rs1990760 C allele was linked to SLE.
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